Medium materiality6/10
NVS Novartis target cut to 156 at Morgan Stanley
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
NVS target lowered to 156 from 170 by Morgan Stanley; current price 140.85. Bearish implications from target revision.
- NVS: Target 156; price 140.85.
Key facts
- 01
Target: $156
- 02
Posted price: $140.85
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Thibault Boutherin
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.